Lyra Therapeutics, Inc.(NasdaqGM:LYRA) dropped from Russell Microcap Value Index
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.305 USD | +1.82% | -1.85% | +1.15% |
Mar. 22 | Lyra Therapeutics Files $300 Million Mixed Shelf Offering | MT |
Mar. 21 | Lyra Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.15% | 311M | |
+3.05% | 42.11B | |
+48.83% | 40.08B | |
+8.30% | 40B | |
-10.82% | 26.87B | |
+7.80% | 24.58B | |
-23.71% | 18.44B | |
+1.62% | 11.94B | |
+32.25% | 11.66B | |
+7.37% | 11.01B |
- Stock Market
- Equities
- LYRA Stock
- News Lyra Therapeutics, Inc.
- Lyra Therapeutics, Inc.(NasdaqGM: LYRA) dropped from Russell Microcap Value Index